Global Discovery Chemistry, Computer-Aided Drug Discovery, Novartis Institutes for BioMedical Research, 181 Mass Ave., Cambridge, MA 02139, USA.
Global Discovery Chemistry, Computer-Aided Drug Discovery, Novartis Institutes for BioMedical Research, 181 Mass Ave., Cambridge, MA 02139, USA.
Biochim Biophys Acta Biomembr. 2017 Feb;1859(2):177-194. doi: 10.1016/j.bbamem.2016.11.005. Epub 2016 Nov 9.
The membrane dipole potential (Ψ) constitutes one of three electrical potentials generated by cell membranes. Ψ arises from the unfavorable parallel alignment of phospholipid and water dipoles, and varies in magnitude both longitudinally and laterally across the bilayer according to membrane composition and phospholipid packing density. In this work, we propose that dynamic counter-balancing between Ψ and the transmembrane potential (ΔΨ) governs the conformational state transitions of voltage-gated ion channels. Ψ consists of 1) static outer, and dynamic inner leaflet components (Ψ and Ψ, respectively); and 2) a transmembrane component (ΔΨ), ariing from differences in intra- and extracellular leaflet composition. Ψ, which transitions between high and low energy states (Ψ and Ψ) as a function of channel conformation, is transduced by the pore domain. ΔΨ is transduced by the voltage-sensing (VS) domain in summation with ΔΨ. Potentiation of voltage-gated ion channels is of interest for the treatment of cardiac, neuronal, and other disorders arising from inherited/acquired ion channel dysfunction. Potentiators are widely believed to alter the rates and voltage-dependencies of channel gating transitions by binding to pockets in the membrane-facing and other regions of ion channel targets. Here, we propose that potentiators alter Ψ and/or Ψ, thereby increasing or decreasing the energy barriers governing channel gating transitions. We used quantum mechanical and molecular dynamics (MD) simulations to predict the overall Ψ-modulating effects of a series of published positive hERG potentiators partitioned into model DOPC bilayers. Our findings suggest a strong correlation between the magnitude of Ψ-lowering and positive hERG potentiation across the series.
膜偶极势(Ψ)是细胞膜产生的三种电势能之一。Ψ 源于磷脂和水分子偶极子的不利平行排列,根据膜组成和磷脂堆积密度,在双层膜的纵向和横向上,其大小都有所不同。在这项工作中,我们提出,Ψ 与跨膜电势(ΔΨ)之间的动态平衡控制着电压门控离子通道的构象状态转变。Ψ 由以下三个部分组成:1)静态外叶和动态内叶成分(分别为 Ψ 和 Ψ);2)跨膜成分(ΔΨ),源自胞内外叶成分的差异。Ψ 随着通道构象的变化在高能态(Ψ 和 Ψ)和低能态之间转换,由孔域转导。ΔΨ 由电压感应(VS)域与 ΔΨ 共同转导。电压门控离子通道的增强对于治疗由遗传性/获得性离子通道功能障碍引起的心脏、神经元和其他疾病具有重要意义。增强剂被广泛认为通过与离子通道靶标的膜面向口袋和其他区域结合,改变通道门控转变的速率和电压依赖性。在这里,我们提出增强剂改变 Ψ 和/或 Ψ,从而增加或减少控制通道门控转变的能量障碍。我们使用量子力学和分子动力学(MD)模拟来预测一系列已发表的阳性 hERG 增强剂在模型 DOPC 双层膜中的总体 Ψ 调节效应。我们的研究结果表明,在整个系列中, Ψ 降低的幅度与阳性 hERG 增强之间存在很强的相关性。